Elsevier

World Neurosurgery

Volume 111, March 2018, Pages e221-e227
World Neurosurgery

Original Article
Utility of Intracranial Pressure Monitoring for Diagnosis of Idiopathic Intracranial Hypertension in the Absence of Papilledema

https://doi.org/10.1016/j.wneu.2017.12.036Get rights and content

Background

Idiopathic intracranial hypertension (IIH) is characterized by headaches, visual obscurations, and papilledema, and the diagnosis involves lumbar puncture (LP) with an elevated opening pressure (OP) ≥20 cm H20. When papilledema is absent, the diagnosis becomes less clear. Some physicians have argued that the absence of papilledema rules out IIH, whereas others maintain that elevated OP is sufficient for diagnosis.

Methods

The authors performed a single-institution 4-year retrospective analysis of patients who underwent invasive intracranial pressure (ICP) monitoring for presumed IIH.

Results

A total of 22 patients were reviewed, and 13 had classic symptoms of IIH, documented elevated OP, and absence of papilledema; 5/13 (38%) patients had proven intracranial hypertension as shown by invasive ICP monitoring, whereas 8/13 (62%) had normal ICP.

Conclusions

With the use of current diagnostic algorithms of clinical presentation and elevated OP, over half of patients without papilledema in our series would be falsely diagnosed with IIH, which could result in unnecessary medical and surgical intervention. Thus, elevated OP as determined by LP is insufficient to diagnose IIH. On the other hand, the absence of papilledema does not rule out intracranial hypertension.

Introduction

Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure (ICP) of unknown cause.1, 2, 3 The symptoms include headaches that are typically exacerbated by lying down and by a Valsalva maneuver.4 Other symptoms include visual disturbances, tinnitus, and dizziness.5, 6, 7, 8 Papilledema and visual field defects are hallmark signs of the disease.3, 9, 10, 11, 12 Although the results of magnetic resonance imaging (MRI) is often normal, findings can include empty sella, flattening of the posterior globes, protrusion of the optic nerve head, optic nerve sheath distention, herniation of the cerebellar tonsils, cerebrospinal fluid (CSF) fistula, and transverse venous sinus stenosis.13, 14, 15

The diagnostic process for IIH is one of exclusion and relies on clinical symptoms and opening pressure (OP) measured by a lumbar puncture (LP).1, 2, 4, 13, 16, 17 In 2014, the IIH Treatment Trial proposed a diagnostic algorithm that used an OP of >20 cm H2O; however, the criteria by Friedman et al.14 2013 and the modified Dandy criteria from 198518, 19 both describe a higher threshold OP criterion of >25 cm H2O.1, 11, 13, 20, 21 Meanwhile, OP can be difficult to assess in anxious patients and in obese patients, who make up the classic demographic of people affected by IIH.22 It can prove difficult to achieve access to the lumbar cistern, and inaccurate measurements are commonly due to incorrect positioning, partial needle obstruction, fluid loss, pharmacologic sedation, moment-to-moment fluctuations, and patient straining.23 A Valsalva maneuver has been shown to increase OP from 14.6 cm H2O to 32.3 cm H2O.24, 25

In many cases, the diagnosis of IIH is straightforward. However, in some cases the optic disc signs are difficult to interpret as a result of congenital anomaly, gliosis, or pallor.23 Meanwhile, visual field results are contingent on the patient's input, which may be unreliable.23 In these circumstances, when papilledema is not clearly identified, intracranial ICP monitoring can prove useful in ruling in, or out, an IIH diagnosis. In a literature review, and to our knowledge, 4 articles have discussed the utility of ICP monitoring in the setting of presumed IIH, although none have looked specifically at patients without papilledema nor compared LP-obtained OP with ICP.22, 23, 26, 27 Moreover, diagnostic algorithms fail to account for patients without papilledema who experience classic IIH symptoms.

We present a series of patients with elevated OP in the absence of papilledema. We aim to corroborate past studies and emphasize a utility for ICP monitoring for selected cases of IIH. We argue that a diagnosis of IIH outside the setting of papilledema warrants more than an elevated OP on LP while also maintaining that absence of papilledema does not rule out intracranial hypertension.

Section snippets

Patient Inclusion

The patients were referred to the neurosurgery team for IIH evaluation. Their symptoms commonly included headaches and visual disturbances, and OP on lumbar puncture were elevated. Funduscopic examinations with pupils dilated were performed by our institution's neuro-ophthalmologists for evidence of papilledema. Table 1 gives details of the patients' characteristics and demographics. The patients were indicated for invasive ICP monitoring when they had met the following criteria: 1) documented

Results

Twenty-two patients had undergone continuous ICP monitoring for workup of presumed IIH in the time period reviewed. There were no complications. Thirteen of these patients had documented elevated OPs and absence of papilledema by ophthalmologic examination; thus, they were included in a full analysis. All 13 patients (12 female) had intact results of on neurologic examination. The mean age was 32 years (range, 15–57 years), and the mean body mass index was 39.5 (range, 23–53) (Table 1). Common

Discussion

Idiopathic intracranial hypertension affects approximately 1 to 2 per 100,000 people and is nearly 20 times more likely to affect obese women of childbearing age.1, 2, 3, 4, 8, 15, 28, 29, 30, 31, 32, 33 Proposed causes include increased venous sinus pressure, decreased CSF absorption, increased CSF secretion, and increased blood volume with cerebral edema.1, 4 Inflammatory markers may also be involved, as may elevated retinol levels.1, 15, 32

Treatment goals include alleviating symptoms while

Conclusions

Continuous intraparenchymal ICP monitoring is an effective and safe diagnostic instrument that should be used in the setting of presumed IIH without papilledema. The OP by LP was falsely elevated in 62% of patients in our cohort, suggesting that OP is insufficient to diagnose IIH in the absence of papilledema. On the other hand, an absence of papilledema does not rule out intracranial hypertension, inasmuch as 38% of our cohort had true elevated ICP outside the setting of papilledema. Thus, we

Acknowledgments

The authors thank Shirley McCartney, Ph.D., for editorial assistance.

References (45)

  • M. Carver et al.

    Assessing idiopathic intracranial hypertension

    Nurse Pract

    (2017)
  • N. Becker et al.

    Rapid improvement of olfaction after lumbar puncture in a patient with idiopathic intracranial hypertension

    Headache

    (2016)
  • E.M. Bershad et al.

    Marked olfactory impairment in idiopathic intracranial hypertension

    J Neurol Neurosurg Psychiatry

    (2014)
  • Z. Liu et al.

    Association between idiopathic intracranial hypertension and sigmoid sinus dehiscence/diverticulum with pulsatile tinnitus: a retrospective imaging study

    Neuroradiology

    (2015)
  • S.M. Stevens et al.

    Idiopathic intracranial hypertension: contemporary review and implications for the otolaryngologist

    Laryngoscope

    (2018)
  • M. Wall et al.

    The idiopathic intracranial hypertension treatment trial: clinical profile at baseline

    JAMA Neurol

    (2014)
  • J. Best et al.

    The incidence of blindness due to idiopathic intracranial hypertension in the UK

    Open Ophthalmol J

    (2013)
  • S.P. Mollan et al.

    Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management

    J Neurol Neurosurg Psychiatry

    (2016)
  • M. Wall et al.

    Idiopathic intracranial hypertension: a prospective study of 50 patients

    Brain

    (1991)
  • S. Bidot et al.

    Brain imaging in idiopathic intracranial hypertension

    J Neuroophthalmol

    (2015)
  • D.I. Friedman et al.

    Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children

    Neurology

    (2013)
  • V. Biousse et al.

    Update on the pathophysiology and management of idiopathic intracranial hypertension

    J Neurol Neurosurg Psychiatry

    (2012)
  • Cited by (6)

    Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    View full text